Stifel analyst Brad Reback downgrades Cognyte Software (NASDAQ:CGNT) from Buy to Hold and lowers the price target from $8 to $6.
STAAR Surgical CEO Caren Mason To Retire; Tom Frinzi Appointed New CEO Effective January 1, 2023
STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31,
